Digital transformation is shaping the future of healthcare. Radically interoperable data, artificial intelligence (AI), and open, secure platforms will drive much of this change. Digital health monitoring plays a vital role in this transformation, allowing easy access to relevant data, improving quality of care and delivering value to patients, healthcare practitioners, hospitals, and governments.
MSD wants to play an active role in accelerating awareness on the benefits of digital health monitoring. This whitepaper is an instrument to initiate the dialogue with all stakeholders and to strengthen the digitalisation of the Belgian healthcare system. It provides the latest insights in the rapidly expanding digital health monitoring market, global case studies, and the current status of digital health monitoring in Belgium.
The global market for digital patient monitoring devices is expected to grow with 28% annually to 273B USD in 2026.
Digital health monitoring solutions provides benefits across diseases and therapeutic areas, with a positive impact on patients, healthcare practitioners, hospitals, and governments, for example:
15% of Belgian hospitals included in the research sample (n=98) are applying digital adverse event management to follow up on oncology patients. The majority of this group facilitates real-time interaction between patient and clinicians through active follow-up on PREMs and PROMs via alerts or pop-ups to patient and hospital in case of severe outcomes.
Key success factors of digitalizing patient follow-up in oncology are:
The Belgian health ecosystem is a splendid nourishing base for digital health solutions as it combines a solid set of start-ups with a favourable legislative framework, enterpreneurial clinicians, and life sciences companies thinking "beyond the pill.